Keigo Akuta, Kentaro Fukushima, Keiichi Nakata, Satoru Hayashi, Jun Toda, Yasuhiro Shingai, Kazuhito Tsutsumi, Tomohisa Machida, Akihisa Hino, Shinsuke Kusakabe, et al. Autoimmune-mediated thrombocytopenia after allogeneic hematopoietic stem cell transplantation: significance of detecting reticulated platelets and glycoprotein-specific platelet autoantibodies. International journal of hematology. 2022. 115. 3. 322-328
Shigeo Fuji, Yuma Tada, Ryo Nakata, Keiichi Nakata, Midori Koike, Shuhei Kida, Kazuhito Tsutsumi, Hiroaki Masaie, Hitoshi Yoshida, Jun Ishikawa. GVHD prophylaxis by tacrolimus and mini-MTX in single-unit CBT: a single institute experience. International journal of hematology. 2020. 111. 2. 278-283
Keiichi Nakata, Shigeo Fuji, Midori Koike, Yuma Tada, Hiroaki Masaie, Hitoshi Yoshida, Eri Watanabe,Seiichiro Kobayashi, Arinobu Tojo, Kaoru Uchimaru, Jun Ishikawa. Successful treatment strategy in corporating mogamulizumab and cord blood transplantation in aggressive adult T-cell leukemia-lymphoma: a case report. BLOOD CELL THERAPY / The official journal of APBMT. 2020. 3. 1
Hitoshi Yoshida, Midori Koike, Yuma Tada, Keiichi Nakata, Akihisa Hino, Shigeo Fuji, Hiroaki Masaie, Chihiro Oka, Akemi Higeno, Atsushi Idota, et al. Different Immune Reconstitution between Cord Blood and Unrelated Bone Marrow Transplantation with Relation to Chronic Graft-versus-Host Disease. International journal of hematology-oncology and stem cell research. 2020. 14. 1. 1-10
吉田 均, 政家 寛明, 藤 重夫, 多田 雄真, 小池 翠, 中田 継一, 紀田 修平, 堤 一仁, 中田 亮, 川上 学, et al. チロシンキナーゼインヒビターの中止基準を満たす慢性骨髄性白血病患者の臨床的特徴(Characteristics of the CML patients who achieve the criteria for the discontinuation of TKIs). 臨床血液. 2018. 59. 9. 1624-1624
2023/12 - American Society of Hematology 2023 ASH Abstract Achievement Award Non-Activating Integrin β3(R734C) Mutation Associated with Macrothrombocytopenia and Impaired Platelet Function